[Retracted] Efficacy Evaluation of High-Volume Hemofiltration in Patients with Severe Acute Respiratory Distress Syndrome

Table 3

Serum levels of miR-126, miR-184, and MAP1-LC3 in the two groups.

Group	Control group (n = 42)	Study group (n = 53)	Ft/Fg	Pt/Pg
miR-126
Before therapy	2.05 ± 0.06	2.06 ± 0.23	5.08/4.14	0.02/0.04
After treatment	1.06 ± 0.13^	0.94 ± 0.52^
miR-184
Before therapy	12.07 ± 4.24	12.64 ± 4.17	4.59/6.20	0.03/0.01
After treatment	5.18 ± 1.33^	2.25 ± 1.61^
MAP1-LC3
Before therapy	1.05 ± 0.38	1.07 ± 0.01	4.31/6.78	0.04/0.01
After treatment	0.60 ± 0.17^	0.41 ± 0.12^

Note: Ft and Pt are the statistical values of time; Fg and Pg are the statistical values of factors between groups; compared with the control group, ; compared with before treatment, ^.